← FDA Drug Approvals (Drugs@FDA)

GEFITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2023-04-26

Drug application

FDA Application #

ANDA208913

Application type

Abbreviated New Drug Application (Generic)

Brand name

GEFITINIB

Generic name

GEFITINIB

Active ingredients

GEFITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS LABS FL INC

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2023-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown